Kingfisher Shares Rise as BQ Owner Weathers Easter Sales Dip Eyes Heatwave Boost Bitcoin Slips Below 77000 Amid Iran Peace Uncertainty and ETF Outflows Prediction Markets Trigger Legal Clash Between States and Federal Regulators Snowflake Boosts Annual Product Revenue Forecast as Enterprise AI Adoption Accelerates Expert Warns Against Buy on Dips Strategy as Market Volatility Persists Says HDFC Securities Devarsh Vakil Rigetti Computing Surges 48 Following 100 Million Government Funding Announcement MTUS Q1 2026 Earnings EPS Surpasses Estimates by 1765 DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress CPIX Q1 2026 Earnings Net Loss Reported Shares Edge Higher VELO Q1 2026 Earnings Strong EPS Beat Shocks Market Revenue Remains Undisclosed CRIS Q1 2026 Earnings Significant EPS Miss Highlights Ongoing PreRevenue Challenges STRS Q3 2023 Earnings Loss Reported Amidst Limited Revenue Visibility Saba Capital Income Opportunities Fund SBI BRW Holds Steady at 675 as Consolidation Persists Boqii Holding BQ Bounces Sharply Potential Breakout Above Resistance Service Properties Trust SVC Holds Above Key Support After Modest Gain Qiagen QGEN Edges Higher A Cautious Breakout from Consolidation OraSure Technologies OSUR Gains 6 Testing Resistance as Momentum Builds Trump Seeks Supreme Court Intervention to Delay TikTok Ban What It Means for Markets Genasys GNSS Q1 2026 Earnings Strong EPS Surprise of 184 Driven by Profitability TriMas Corporation TRS Edges Higher Amid Steady Trading Key Levels in Focus Silver Prices Decline on MCX Amid Strengthening Dollar and Rising Oil Prices AGCO Q1 2026 Earnings Massive EPS Beat Masks Broader Market Concerns The Hartford Q1 2026 Earnings EPS Falls Short on Underwriting Pressure Wison New Energies Marks 17Year US Expansion Milestone with First Floating Wind Patent at OTC 2026 Tokenization May Reshape Credit Markets Says Strategys Michael Saylor SF Q1 2026 Earnings Stifel Financial Beats EPS Estimates by 1 Amid Mixed Market Response Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline